Hebo Pharmaceutical-B announced that with effect from September 7, 2026, the company's shares will be included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect share lists. Eligible investors in mainland China can directly invest in shares through the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.

Zhitongcaijing · 1d ago
Hebo Pharmaceutical-B announced that with effect from September 7, 2026, the company's shares will be included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect share lists. Eligible investors in mainland China can directly invest in shares through the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.